MOEBIUS MEDICAL
Moebius Medical is developing MM-II, a novel liposome-based bio-lubricant for long-term treatment of osteoarthritis. Based on the clinical data from its recently completed first-in-man study, MM-II shows significant promise as the next generation intra-articular treatment for OA. MM-II`s success is due to its unique composition of liposomes, which act as "biological ball bearings". Its structure and superior mechanical lubrication properties facilitate cartilage surface gliding, thus preventing further wear and friction, as well as subsequent joint damage.
MOEBIUS MEDICAL
Industry:
Health Care Health Diagnostics Medical
Founded:
2008-01-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.moebiusmedical.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible WordPress Euro Contact Form 7 Vimeo WordPress 5.9 WP Rocket
Similar Organizations
frankie
frankie is a rewards-based mental health and wellness app that enhances emotional well being with the help of daily tasks.
Official Site Inspections
http://www.moebiusmedical.com
- Host name: 43.97.215.35.bc.googleusercontent.com
- IP address: 35.215.97.43
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Moebius Medical"
Moebius Medical – Proprietary liposomal technologies
Moebius Medical is an innovative clinical-stage biotech company that leverages its proprietary liposomal technologies and related expertise in the development of novel products.See details»
Moebius Medical Ltd. - LinkedIn
Moebius leverages its proprietary liposomal technologies and related expertise in the development of novel products for unmet medical needs.See details»
Moebius Medical - Pain Relief for Osteoarthritis | Startup Nation …
Dec 13, 2016 · Moebius Medical is a clinical-stage biotechnology company developing novel pain-relief treatments for osteoarthritis. The company's lead product, MM-II, is a patent-protected …See details»
Moebius Medical - Crunchbase Company Profile & Funding
View contacts for Moebius Medical to access new leads and connect with decision-makers. Moebius Medical is developing MM-II, a novel liposome-based bio-lubricant for long-term …See details»
Moebius Medical - PitchBook
Operator of a clinical-stage biotechnology company intended to develop novel pain-relief treatments for the treatment of osteoarthritis.See details»
Moebius Medical - Overview, News & Similar companies - ZoomInfo
Moebius Medical (www.moebiusmedical.com) is a clinical stage biotechnology company that is developing novel treatments for osteoarthritis. The company's lead product, MM-II, is based on …See details»
Moebius Medical Ltd. - Company Profile & Staff Directory
Moebius leverages its proprietary liposomal technologies and related expertise in the development of novel products for unmet medical needs.See details»
Moebius Medical - Pain Relief for Osteoarthritis | Start-Up Nation …
Find out more about Moebius Medical's founders and team members at Start-Up Nation Finder!See details»
Moebius Medical Announces FDA Clearance of IND Application …
Dec 21, 2020 · MM-II is a novel non-opioid intra-articular injection that leverages the physical properties of proprietary liposomes and an innovative mechanism-of-action to provide …See details»
Moebius Medical - Products, Competitors, Financials, Employees ...
Moebius Medical is a clinical-stage biotech company focused on developing novel products using proprietary liposomal technologies. Use the CB Insights Platform to explore Moebius Medical's …See details»
Moebius Medical - VentureRadar
Website: http://www.moebiusmedical.com Moebius Medical is developing a novel bio-lubricant. The treatment shows great promise for osteoarthritic patients Mapped in IsraelSee details»
Sun Pharma & Moebius Medical Sign Exclusive Global Licensing …
Dec 12, 2016 · Moebius Medical is an innovative clinical stage biotechnology company that is developing novel pain relief treatments for osteoarthritis.See details»
More News - FDA Health News
Dec 21, 2020 · Israel-based Moebius Medical today announced that the US Food and Drug administration (FDA) has cleared their Investigational New Drug (IND) application to initiate a …See details»
Moebius Medical Ltd. Financial Overview, Employee Count, and ...
View Moebius Medical Ltd. (http://www.moebiusmedical.com) location in Tel Aviv District, Israel, revenue, competitors and contact information. Find and reach Moebius Medical Ltd.'s …See details»
Oral Presentation at EULAR 2024 of Data from Global Phase 2b …
Sun Pharma and Moebius Medical, who have been jointly developing this product, have announced plans to initiate a Phase 3 clinical program and to seek a CE Mark for the product …See details»
Moebius Medical Ltd. | Insights
Dec 13, 2016 · Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Moebius Medical Announces Dosing of First Patient in Global
TEL AVIV, Israel, Feb. 16, 2021 /PRNewswire/ -- Israel-based Moebius Medical today announced that the first patient has been dosed in its Phase IIb clinical trial of MM-II, a novel candidate for …See details»
Sun Pharma and Moebius Medical Announce Fast Track …
Ection of 3mL of MM-II provided greater pain relief than placebo for up to 26 weeks and were recently presented at EULAR 2024. Sun Pharma and Moebius Medical, who have been jointly …See details»
FOR IMMEDIATE RELEASE - Sun Pharma
Clinical stage biotechnology company that is developing novel pain relief treatments for osteoarthritis. The company was founded in 2008 within the RAD Biomed Accelerator to …See details»
Moebius Medical Announces Dosing of First Patient in Global …
TEL AVIV, Israel, Feb. 16, 2021 /PRNewswire/ -- Israel-based Moebius Medical today announced that the first patient has been dosed in its Phase IIb clinical trial of MM-II, a novel candidate for...See details»